Winter KA - Search Results

1

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial.

Kim IA, Winter KA, Sperduto PW, De Los Santos JF, Peereboom DM, Ogunleye T, Boulter D, Fritz JM, Cho KH, Shin KH, Zoberi I, Choi S, Palmer JD, Liem B, Kim YB, Anderson BM, Thakrar AW, Muanza TM, Kim MM, Choi DH, Mehta MP, White JR. Kim IA, et al. Among authors: winter ka. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1391-1401. doi: 10.1016/j.ijrobp.2023.07.019. Epub 2023 Jul 26. Int J Radiat Oncol Biol Phys. 2024. PMID: 37506981 Clinical Trial.

2

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group.

Lawton CA, Winter K, Byhardt R, Sause WT, Hanks GE, Russell AH, Rotman M, Porter A, McGowan DG, DelRowe JD, Pilepich MV. Lawton CA, et al. Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):931-9. doi: 10.1016/s0360-3016(97)00288-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9276357 Clinical Trial.

3

Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.

Vijayakumar S, Winter K, Sause W, Gallagher MJ, Michalski J, Roach M, Porter A, Bondy M. Vijayakumar S, et al. Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):17-25. doi: 10.1016/s0360-3016(97)00834-1. Int J Radiat Oncol Biol Phys. 1998. PMID: 9422553

4

Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.

Grigsby PW, Winter K, Wasserman TH, Marcial V, Rotman M, Cooper J, Keys H, Asbell SO, Phillips TL. Grigsby PW, et al. Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):513-7. doi: 10.1016/s0360-3016(99)00054-1. Int J Radiat Oncol Biol Phys. 1999. PMID: 10348279 Clinical Trial.

5

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.

Lawton CA, Winter K, Murray K, Machtay M, Mesic JB, Hanks GE, Coughlin CT, Pilepich MV. Lawton CA, et al. Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):937-46. doi: 10.1016/s0360-3016(00)01516-9. Int J Radiat Oncol Biol Phys. 2001. PMID: 11240234 Clinical Trial.

6

Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy.

Horwitz EM, Winter K, Hanks GE, Lawton CA, Russell AH, Machtay M. Horwitz EM, et al. Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):947-56. doi: 10.1016/s0360-3016(00)01443-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11240235 Clinical Trial.

7

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.

Pilepich MV, Winter K, John MJ, Mesic JB, Sause W, Rubin P, Lawton C, Machtay M, Grignon D. Pilepich MV, et al. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1243-52. doi: 10.1016/s0360-3016(01)01579-6. Int J Radiat Oncol Biol Phys. 2001. PMID: 11483335 Clinical Trial.

8

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.

Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Michalski JM, et al. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):192-8. doi: 10.1016/s0360-3016(03)00072-5. Int J Radiat Oncol Biol Phys. 2003. PMID: 12694838

9

Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.

Michalski JM, Winter K, Purdy JA, Perez CA, Ryu JK, Parliament MB, Valicenti RK, Roach M 3rd, Sandler HM, Markoe AM, Cox JD. Michalski JM, et al. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):735-42. doi: 10.1016/S0360-3016(03)01578-5. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967428 Clinical Trial.

10

Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.

Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Bradley J, et al. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):318-28. doi: 10.1016/j.ijrobp.2004.06.260. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667949 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page